Citations

Clear

2117 citation(s) found for "Mayo, Steven".

Tolerability and Outcomes for Treatment of Older Myxoid Liposarcoma Population
Coombs, Reilly A. , Thangaiah, Judith Jebastin, Okuno, Scott H. , Houdek, Matthew T. , Xu‐Welliver, Meng , Ho, Thanh P. , Jebastin Thangaiah, Judith, Okuno, Scott , Houdek, Matthew T , Xu-Welliver, Meng , Ho, Thanh P , Siontis, Brittany L. , Robinson, Steven I.

Mayo Clinic

Cancers | September 23, 2024 | Volume: 16 | Issue: 18 | Pages: 3233

10.3390/cancers16183233 | PMID 39335204 Get It

Background: Myxoid liposarcoma predominantly affects young and middle-aged individuals, and little is known regarding treatment tolerability and outcomes in older patients. This study aims to better understand this older patient population. Methods: This single institution retrospective study included patients aged 70 years and older with localized (non-metastatic) myxoid liposarcoma. Results: Sixteen patients were included. The median age was 75 years, and 9 (56%) were female. Fourteen (88%) were extremity tumors and two (12%) were trunk. The median tumor size was 10.4 cm (range, 3.6 to 28 cm). Five (31%) tumors had a round cell component. All patients had surgery. Fourteen (88%) had perioperative radiation, and three (19%) had perioperative chemotherapy. One patient had postoperative infection, and one patient had neutropenic fever from preoperative chemotherapy. The median follow up from surgery was 6.3 years. Eight (50%) patients died from MLPS. The median relapse-free survival and overall survival were 34 months and 75 months, respectively. Conclusions: Most older patients with localized MLPS received perioperative radiation therapy with surgery, and few serious toxicities were reported. Even with treatment, half of the patients relapsed.
Peroral endoscopic myotomy as a treatment for Killian–Jamieson diverticulum (KJ-POEM)
Assefa, Redeat Libanos, Bejjani, Michael , Mehta, Amit , Shrigiriwar, Apurva , Shimamura, Yuto , Inoue, Haruhiro , Mandarino, Francesco Vito , Bowers, Steven P. , Arevalo, Martha, Andrisani, Gianluca , Sampath, Kartik, Khashab, Mouen A., Shimamura, Yuto , Mandarino, Francesco Vito , Lajin, Michael , Assefa, Redeat, Fayyaz, Farimah , Azzolini, Francesco , Li, Zhen , Robles‐Medranda, Carlos , Arevalo-Mora, Martha , Dhir, Vinay K. , Tanțău, Alina Ioana , Khashab, Mouen A.

Mayo Clinic

Endoscopy International Open | September 18, 2024 | Volume: 12 | Issue: 10 | Pages: E1214-E1219

10.1055/a-2399-7464 | PMID 39474487 Get It

Abstract Background and study aims Killian-Jamieson diverticulum (KJD) is a rare type of esophageal diverticulum that occurs in a specific area called the Killian-Jamieson space. Although surgery has been the conventional treatment for symptomatic KJD, minimally invasive endoscopic techniques, particularly Killian-Jamieson per-oral endoscopic myotomy (KJ-POEM), have emerged as an alternative. The aim of the study was to evaluate the effectiveness and safety of KJ-POEM in treating KJD. Patients and methods This was an international, multicenter, retrospective study that included patients who underwent KJ-POEM for symptomatic KJD from October 16, 2018 to April 12,2023. The primary outcome was clinical success, defined as complete or near-complete resolution of symptoms (i.e., post-procedure Kothari-Haber Score ≤ 2). Secondary outcomes were technical success (defined as successful completion of all procedural steps), rate and severity of adverse events (AEs), total procedure duration, and symptom recurrence during follow-up. Results A total of 13 patients (mean age 65.23 years, 6 female) with KJD and a mean pre-procedure Kothari-Haber Score of 6 (standard deviation [SD] 2.16) underwent KJ-POEM across 10 participating centers. Clinical success and technical success were achieved in all cases (100%) with a mean post-procedure Kothari-Haber Score of 0.91 (SD 0.99). There were no AEs and no cases of injury to the recurrent laryngeal nerve. Mean length of hospital stay was 1.09 days (SD 0.74). Mean follow-up time was 9.41 months (SD 10.07) post-procedure. There was no post-procedure symptom recurrence any patient. Conclusions KJ-POEM is a safe and effective alternative treatment for symptomatic KJD with excellent short/mid-term outcomes.
Unplanned Excision of Synovial Sarcoma: Factors Associated with Recurrence and Survival
Broida, Samuel E. , Arguello, Alexandra M. , Sullivan, Mikaela H. , Okuno, Scott H. , Ho, Thanh P. , Rose, Peter S. , Xu‐Welliver, Meng , Houdek, Matthew T. , Okuno, Scott , Ho, Thanh P , Xu-Welliver, Meng , Houdek, Matthew T , Broida, Samuel E , Robinson, Steven I. , Siontis, Brittany L.

Mayo Clinic

Cancers | September 16, 2024 | Volume: 16 | Issue: 18 | Pages: 3157

10.3390/cancers16183157 | PMID 39335129 Get It

Background: Synovial sarcoma is rare and may present as a small, slow-growing mass. These tumors are often mistaken as benign and are therefore prone to unplanned and/or non-oncologic excision. We sought to identify the rate of unplanned excision of synovial sarcoma and risk factors for recurrence and survival among this cohort. Methods: The medical records of 246 patients evaluated at a single institution for synovial sarcoma between 1997 and 2022 were retrospectively reviewed. Of these, 87 (35%) underwent unplanned, non-oncologic excision. The mean age of the cohort was 49 years. Primary tumors were located in the extremity (n = 63), abdomen (n = 6), thorax (n = 7), head/neck (n = 8), and paraspinal region (n = 3). The median maximum pre-treatment dimension of the primary tumor was 4.8 cm (IQR 7–2.4). Seventy-seven (86%) patients underwent re-excision of the tumor bed, 39 (45%) received chemotherapy, and 63 (72%) received radiation therapy. Results: Among patients who underwent unplanned excision, local recurrence-free survival (LRFS) was 98% at 1 year and 82% at 5 years. Metastasis-free survival (MFS) was 91% at 1 year and 72% at 5 years. Disease-specific survival (DSS) was 98% at 1 year and 72% at 5 years. When adjusting for tumor size, tumors which underwent unplanned excision did not have worse recurrence or survival compared to those which had planned excision (p > 0.10). Size > 5 cm, monophasic subtype, and axial location were associated with increased risk of disease recurrence. Forty-six patients had residual tumor following re-excision, which was associated with worse MFS (HR 8.17, 95% CI [1.89, 35.2], p < 0.01) and DSS (HR 7.66, 95% CI [1.76, 33.4], p < 0.01). Patients who received radiotherapy had improved MFS (HR 6.4, 95% CI [1.42, 29.0], p = 0.02) and DSS (HR 5.86, 95% CI [1.27, 26.9], p = 0.02). Conclusions: One-third of patients presenting with synovial sarcoma were diagnosed after unplanned, non-oncologic excision. Patients with large, axial tumors had worse survival. Approximately half of patients who underwent unplanned excision had no residual tumor after pre-operative radiation. The use of radiation was associated with decreased rates of recurrence and improved disease-specific survival. Our results suggest that margin-negative re-resection and radiotherapy should be considered when feasible following unplanned excision of synovial sarcoma.
The Role of Cardiovascular Imaging in the Diagnosis of Athlete’s Heart: Navigating the Shades of Grey
Ali, Nima Baba , Esfahani, Sogol Attaripour , Scalia, Isabel G. , Farina, Juan M. , Pereyra, Milagros , Barry, Timothy , Lester, Steven J., Alsidawi, Said , Steidley, D. Eric , Ayoub, Chadi , Palermi, Stefano , Arsanjani, Reza , Baba Ali, Nima , Attaripour Esfahani, Sogol, Steidley, David E, Arsanjani, Reza , Farina, Juan M , Pereyra, Milagros , Alsidawi, Said , Scalia, Isabel G

Mayo Clinic

Journal of Imaging | September 16, 2024 | Volume: 10 | Issue: 9 | Pages: 230

10.3390/jimaging10090230 | PMID 39330450 Get It

Athlete’s heart (AH) represents the heart’s remarkable ability to adapt structurally and functionally to prolonged and intensive athletic training. Characterized by increased left ventricular (LV) wall thickness, enlarged cardiac chambers, and augmented cardiac mass, AH typically maintains or enhances systolic and diastolic functions. Despite the positive health implications, these adaptations can obscure the difference between benign physiological changes and early manifestations of cardiac pathologies such as dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), and arrhythmogenic cardiomyopathy (ACM). This article reviews the imaging characteristics of AH across various modalities, emphasizing echocardiography, cardiac magnetic resonance (CMR), and cardiac computed tomography as primary tools for evaluating cardiac function and distinguishing physiological adaptations from pathological conditions. The findings highlight the need for precise diagnostic criteria and advanced imaging techniques to ensure accurate differentiation, preventing misdiagnosis and its associated risks, such as sudden cardiac death (SCD). Understanding these adaptations and employing the appropriate imaging methods are crucial for athletes’ effective management and health optimization.
Cardiac Metastasis from Myxoid Liposarcoma Managed Successfully with Chemotherapy and Radiotherapy: Case Report and Review of the Literature
Stergiopoulos, Georgios M. , Petersen, Ivy A. , Houdek, Matthew T. , Ho, Thanh P. , Okuno, Scott H. , Houdek, Matthew T , Ho, Thanh P , Okuno, Scott , Siontis, Brittany L. , Robinson, Steven I.

Mayo Clinic

Current Oncology | September 12, 2024 | Volume: 31 | Issue: 9 | Pages: 5384-5398

10.3390/curroncol31090398 | PMID 39330026 Get It

Background: Liposarcoma, one of the most prevalent sarcoma histologies, is recognized for its tendency for extra-pulmonary metastases. While oligometastatic cardiac disease is rarely reported, it poses a unique challenge as oligometastatic sarcomas are often managed with surgical resection. Case Report: We present a case of a 62-year-old man diagnosed with an oligometastatic myxoid liposarcoma (MLPS) to the heart 19 years after the primary tumor resection from the lower limb. The metastatic mass, situated in the pericardium adjacent and infiltrating the left ventricle, was not managed surgically but with a combination of chemotherapy and radiotherapy. The patient’s disease remains stable to date, for more than 10 years. Literature Review: We conducted a review of the literature to determine the preferred management approach for solitary cardiac metastases of sarcomas. We also conducted an in-depth analysis focusing on reported cases of MLPS metastasizing to the heart, aiming to extract pertinent data regarding the patient characteristics and the corresponding management strategies. Conclusions: Although clinical diagnoses of solitary or oligometastatic cardiac metastases from sarcomas are infrequent, this case underscores the significance of aggressive management employing chemotherapy and radiotherapy for chemosensitive and radiosensitive sarcomas, especially when surgical removal is high-risk. Furthermore, it challenges the notion that surgery is the exclusive therapeutic option leading to long-term clinical benefit in patients with recurrent sarcomas.
Central role for cholangiocyte pathobiology in cholestatic liver diseases
Jalan‐Sakrikar, Nidhi , Guicciardi, Maria Eugenia , O’Hara, Steven P. , Azad, Adiba , Gores, Gregory J., Huebert, Robert C. , Huebert, Robert , Sakrikar, Nidhi Jalan , LaRusso, Nicholas F. , Gores, G. J.

Mayo Clinic

Hepatology | September 9, 2024 | Volume: 82 | Issue: 4 | Pages: 834-854

10.1097/hep.0000000000001093 | PMID 39250501 Get It

Cholangiopathies comprise a spectrum of chronic intrahepatic and extrahepatic biliary tract disorders culminating in progressive cholestatic liver injury, fibrosis, and often cirrhosis and its sequela. Treatment for these diseases is limited, and collectively, they are one of the therapeutic “black boxes” in clinical hepatology. The etiopathogenesis of the cholangiopathies likely includes disease-specific mediators but also common cellular and molecular events driving disease progression (eg, cholestatic fibrogenesis, inflammation, and duct damage). The common pathways involve cholangiocytes, the epithelial cells lining the intrahepatic and extrahepatic bile ducts, which are central to the pathogenesis of these disorders. Current information suggests that cholangiocytes function as a signaling “hub” in biliary tract-associated injury. Herein, we review the pivotal role of cholangiocytes in cholestatic fibrogenesis, focusing on the crosstalk between cholangiocytes and portal fibroblasts and HSCs. The proclivity of these cells to undergo a senescence-associated secretory phenotype, which is proinflammatory and profibrogenic, and the intrinsic intracellular activation pathways resulting in the secretion of cytokines and chemokines are reviewed. The crosstalk between cholangiocytes and cells of the innate (neutrophils and macrophages) and adaptive (T cells and B cells) immune systems is also examined in detail. The information will help consolidate information on this topic and guide further research and potential therapeutic strategies for these diseases.
Deep Learning in Automating Breast Cancer Diagnosis from Microscopy Images
Gu, Qiangqiang , Prodduturi, Naresh, Hart, Steven N.

Mayo Clinic

2024 Design of Medical Devices Conference | August 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1115/dmd2024-1017 Get It

Abstract Breast cancer is one of the most common cancers in women. With early diagnosis, some breast cancers are highly curable. Classifying normal versus tumor breast tissues from microscopy images is an ideal case to use for deep learning and could help diagnose breast cancer with higher reproducibility. Since data preprocessing and hyperparameter tuning have impacts on breast cancer classification accuracies, training a classifier with appropriate data preprocessing and optimized hyperparameters could improve breast cancer classification accuracy. Using 12 combinations of model architectures, data preprocessing, and hyperparameter configurations, the validation accuracy was calculated using the BreAst Cancer Histology (BACH) dataset. The DenseNet201, a non-specialized model architecture, with transfer learning approach achieved 98.61% validation accuracy compared to only 64.00% for the digital pathology (DP)-specialized model architecture. The combination of image data preprocessing and hyperparameters have a profound impact on the performance of deep neural networks for image classification. To identify a well-performing neural network to classify tumor versus normal breast histology, researchers should not only focus on developing new models specifically for DP, since hyperparameter tuning for existing deep neural networks in the computer vision field could also achieve a better prediction accuracy.
Mitochondrial RNA cytosolic leakage drives the SASP
Victorelli, Stella , Eppard, Madeline, Woo, Seung‐Hwa , Everts, Stacia , Martini, Hélène , Pirius, Nicholas, Franco, Ana Catarina , Han, Yeaeun , Saul, Dominik , Splinter, Patrick L., O’Hara, Steven P. , Valenzuela-Pérez, Lucía , Lee, Hyun Se Kim , Jurk, Diana , Everts, Stacia P A, LaRusso, Nicholas F , Hirsova, Petra , Passos, João F , Jurk, Diana , Kim Lee, Hyun Se , Saul, Dominik , Lee, Gung , Han, Nuan , Liang, Eugene Y., Nóvoa, Eva , Nogueiras, Rubén , Morgenthaler, Olivia , LaRusso, Nicholas F. , Passos, João F.

Mayo Clinic

No container title available | August 26, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-4876596/v1 | PMID 39257994 Get It

Abstract Senescent cells secrete proinflammatory factors known as the senescence-associated secretory phenotype (SASP), contributing to tissue dysfunction and aging. Mitochondrial dysfunction is a key feature of senescence, influencing SASP via mitochondrial DNA (mtDNA) release and cGAS/STING pathway activation. Here, we demonstrate that mitochondrial RNA (mtRNA) also accumulates in the cytosol of senescent cells, activating RNA sensors RIG-I and MDA5, leading to MAVS aggregation and SASP induction. Inhibition of these RNA sensors significantly reduces SASP factors. Furthermore, BAX and BAK plays a key role in mtRNA leakage during senescence, and their deletion diminishes SASP expression in vitro and in a mouse model of Metabolic Dysfunction Associated Steatohepatitis (MASH). These findings highlight mtRNA's role in SASP regulation and its potential as a therapeutic target for mitigating age-related inflammation.
Proximal row carpectomy or scaphoid excision and four-corner arthrodesis for treatment of scapholunate advanced collapse arthritis
Lin, James S. , Moran, Steven L.

Mayo Clinic

Journal of Hand Surgery (European Volume) | August 22, 2024 | Volume: 50 | Issue: 1 | Pages: 68-75

10.1177/17531934241265838 | PMID 39169776 Get It

Degenerative wrist conditions, such as scapholunate advanced collapse and scaphoid nonunion advanced collapse, often require salvage procedures to reduce pain and improve function. For early stages of disease, both proximal row carpectomy and scaphoid excision four-corner arthrodesis are viable motion-preserving options. There remains controversy on which technique is superior. Selection is a nuanced decision that requires consideration of patient characteristics and stage of disease. The traditional notion that proximal row carpectomy should be reserved for older individuals with low demands has been challenged; long-term studies in younger populations demonstrate similar patient-reported outcomes, pain relief and survivorship without conversion to total wrist arthrodesis between proximal row carpectomy and four-corner arthrodesis. The existing evidence suggests proximal row carpectomy has advantages of greater range of motion, fewer complications and lower costs. Advancements such as arthroscopic techniques for both procedures show potential, although mastery involves a steep learning curve.
Rapid healthcare innovation during the COVID-19 pandemic
Crowley, Steven D. , Henson, Jammie M., Andrist, Jesse D., Elsen, Sandra J., Ziegler, Jeff R., Doppler, Julie M.

Mayo Clinic

Management in Healthcare: A Peer-Reviewed Journal | July 25, 2024 | Volume: 5 | Issue: 3 | Pages: 202

10.69554/kwom4974 Get It

The COVID-19 pandemic challenged healthcare organisations in safely providing healthcare to patients while protecting employees and reducing the spread of the virus. This paper shows how the Mayo Clinic responded by implementing innovations, including screening, testing and tracing patients for COVID-19; expanding telehealth services; adjusting surgical and procedural operations and reallocating staffing and supplies. These changes were operationalised rapidly through the coordinated response from its leadership, partnership of experts across the organisation, prompt decision-making driven by data, redistribution of resources and expedited training. These innovations and methods of rapid implementation enabled Mayo Clinic to safely continue its mission of providing healing and hope to its patients worldwide, and quickly return to financial sustainability.